Looking to list your PhD opportunities? Log in here.
We have 15 Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford
Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford
We have 15 Pharmaceutical Chemistry PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Bradford
PhD students in Pharmaceutical Chemistry research a range of chemical compounds and their impact on human health. You could be examining the design, synthesis, and evaluation of therapeutics or working on leading-edge research into infectious diseases and antimicrobial resistance.
What's it like to study a PhD in Pharmaceutical Chemistry?
With a PhD in Pharmaceutical Chemistry, you'll have the opportunity to build your own unique research portfolio. You could be focusing on the development of therapeutics, drug delivery systems and vaccines, or using cutting-edge techniques such as mass spectrometry to study disease.
Possible research areas include:
- Pharmaceutical analysis
- Pharmacology
- Pharmaceutical research and development
- Pharmacokinetics and pharmacodynamics
- Biopharmacy and biotherapeutics
You'll take part in research rotations to gain expertise in certain areas of Pharmaceutical Chemistry. You will have the opportunity to collaborate with local hospitals and connect with the wider scientific community through attending conferences and publishing papers.
Most PhD programmes in Pharmaceutical Chemistry last 3-4 years. Your project may have a research training component, which connects you with the wider aim of your department and university. You will submit an approximately 80,000-word thesis to be defended at the end of your study.
PhD in Pharmaceutical Chemistry entry requirements
The minimum entry requirement for a PhD in Pharmaceutical Chemistry is usually a 2:1 undergraduate degree in a relevant subject, although a Masters may occasionally be required.
Some PhDs in Pharmaceutical Chemistry may ask you to express an interest in certain research areas.
PhD in Pharmaceutical Chemistry funding options
In the UK, PhDs in Pharmaceutical Chemistry can be funded by the Medical Research Council (MRC), which provides a tuition fee waiver and a living cost stipend.
You may have to self-fund in which case you can look at government loans, university scholarships and charities and trusts for funding.
PhD in Pharmaceutical Chemistry careers
There are many career options for graduates with a PhD in Pharmaceutical Chemistry. You could take up a postdoctoral position at a university or pharmaceutical company, or you might decide to apply your scientific knowledge through roles in regulatory affairs.
The Biosynthesis of Neurotransmitter Molecules: An evolutionary perspective
Superselective targeting of cancer and neuronal cells using multivalent lectin-glycan interactions
High Pressure Dissolved Gas Reactor Concept
Broadening the spectrum of antibacterial drugs to tackle multi-drug resistant Gram-negative pathogens
Predictive control of crystallisation through correlative studies of molecular fragments
Predictive control of crystallisation through correlative studies of molecular fragments
Sustainable and controlled drug delivery to fight global antimicrobial resistance (AMR) using hybrid porous nano containers
Formulation of heterogenous solid dispersions produced by spray drying and hot-melt extrusion for improved delivery of amorphous drugs
Formulation and biopharmaceutical characterisation of novel pro-antibiotics for improved oral permeability
Directed Co-Crystallisation of Pharmaceuticals: developing a predictive method for co-crystallisation
Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
Biodegradable composite materials (Bio-PolyMOFs) for applications in targeted delivery of drugs to improve healthcare and reduce antimicrobial resistance in developing countries and worldwide
Therapeutic resolution of BMPR2-mediated signalling defects in pulmonary arterial hypertension (PAH)
Therapeutic resolution of Myelodysplastic Syndrome (MDS) by natural products
- 1